Editorial from Editor-in-Chief (Thematic Issue: Cystic Fibrosis Treatment: Are We There Yet?)

Ishay      Leff-Podoswa; Joseph      Varon

doi:10.2174/1573398X0904140129124659

Author(s): Ishay Leff-Podoswa and Joseph Varon

Volume 9, Issue 4, 2013

Page: [225 - 226] Pages: 2

DOI: 10.2174/1573398X0904140129124659

Keywords: Cystic fibrosis, treatment, inhaled antibiotics, DNA vector, airway clearance.

Download Options

Rights & Permissions Print Cite

Current Respiratory Medicine Reviews

Title:Editorial from Editor-in-Chief (Thematic Issue: Cystic Fibrosis Treatment: Are We There Yet?)

Volume: 9 Issue: 4

Author(s): Ishay Leff-Podoswa and Joseph Varon

Affiliation:

Keywords: Cystic fibrosis, treatment, inhaled antibiotics, DNA vector, airway clearance.

Export Options

Export File:

RIS (for EndNote, Reference Manager, ProCite)

BibTeX

Text

Content:

Citation Only

Citation and Abstract

About this article

Cite this article as:

Leff-Podoswa Ishay and Varon Joseph, Editorial from Editor-in-Chief (Thematic Issue: Cystic Fibrosis Treatment: Are We There Yet?), Current Respiratory Medicine Reviews 2013; 9 (4) . https://dx.doi.org/10.2174/1573398X0904140129124659

DOI https://dx.doi.org/10.2174/1573398X0904140129124659	Print ISSN 1573-398X
Publisher Name Bentham Science Publisher	Online ISSN 1875-6387

About this journal

Call for Papers in Thematic Issues

Submission closes on : 31 December, 2025

Chronic obstructive pulmonary disease (COPD) from childhood to adulthood: from the past to the future

Chronic obstructive pulmonary disease (COPD) is one of the three leading causes of death worldwide, with a major prevalence in low- and middle-income countries, resulting in a high social and economic cost. It is a heterogeneous respiratory disease, treatable and preventable, that causes persistent and often progressive airway obstruction in ...read more

Guest Editor(s): Dr. Paolo Ruggeri